CATHERINE MCCULLEY: Open Payments
NPI 1881235471 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 26 payments from 12 companies in 2025. Trend: 2023 $913 · 2024 $1,049 · 2025 $493
Food & beverage: $447Education: $47
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 10 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $89 |
| Viatris Specialty LLC | 2 | $49 |
| Grifols USA, LLC | 2 | $44 |
| PFIZER INC. | 1 | $32 |
| Electromed, Inc. | 2 | $29 |
| Amgen Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
Products named: Arikayce, JASCAYD, YUPELRI, Prolastin-C Liquid, TEZSPIRE, Brinsupri, OCTAGAM IMMUNE GLOBULIN (HUMAN), SMARTVEST.
Industry payments across SD — which companies pay providers there.
